The Early Diagnosis of Alzheimer’s Disease: Exploring Pathological Obstacles

International Conference on Alzheimer’s and Parkinson’s Disease 2019

Welcome and Introduction
Meet Our Patient: A Case Study for Discussion

Panel chair José Luis Molinuevo, MD, PhD, introduces the symposium’s topics, objectives, and expert panelists. He discusses the level of preparedness of EU healthcare systems for confirming a diagnosis early in the Alzheimer’s disease continuum, based on the findings of the EU RAND report. Finally, he introduces a patient case study, which describes the journey of a patient with Alzheimer’s disease, from initial presentation to receiving a diagnosis.

Download Key Learnings

Summary of key learnings from Biogen's ADPD 2019 Symposium

Key Learning Objectives for Biogen’s ADPD 2019 Symposium:

  • Understand the importance of an accurate and timely diagnosis of Alzheimer’s disease
  • Review the diagnostic challenges of a mixed pathology in patients with Alzheimer’s disease
  • Increase understanding of how comprehensive clinical assessments and a range of imaging and fluid biomarkers can be used in the timely diagnosis of a complex case of Alzheimer’s disease
  • Raise awareness of the current healthcare system readiness for a paradigm shift to early diagnosis of Alzheimer’s disease

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.